1 Result(s)

Article

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

Daratumumab plus lenalidomide and dexamethasone (D-Rd) and bortezomib plus lenalidomide and dexamethasone (VRd) are commonly used treatment combinations for transplant-ineligible (TIE) patients with newly diag...

Brian G. M. Durie, Shaji K. Kumar, Eric M. Ammann, Alex Z. Fu… in Advances in Therapy (2024)